GlassScriptPhysician profile
Andrew Onshing Chow
NPI 1376583245
$3,473.47
in general payments reported to CMS, 2019-2025
35 companies · $1,197 in 2025
The $1,197 reported for 2025 was more than what 95% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $343 · 2023: $959 · 2024: $974 · 2025: $1,197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,130.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $905.98 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $585.85 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $373.68 | 2022-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $300.75 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $224.32 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $120.82 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.05 | 2022-2025 | Jardiance |
| Exact Sciences Corporation | $92.06 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $90.40 | 2023-2024 | Trelegy Ellipta, Shingrix |
| Corium, LLC | $59.41 | 2023 | Adlarity |
| Xeris Pharmaceuticals, INC. | $49.06 | 2022-2024 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $47.35 | 2022-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Abbott Laboratories | $40.74 | 2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.54 | 2024-2025 | Caplyta |
| Shield Therapeutics INC | $36.46 | 2024-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $32.04 | 2023-2024 | Repatha, Otezla |
| Dexcom, INC. | $30.29 | 2024 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $29.67 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $28.01 | 2025 | Rexulti |
| Lundbeck LLC | $24.18 | 2025 | Rexulti |
| Medtronic, INC. | $24.07 | 2024 | Kyphon Express II Kyphopak Tray |
| Corcept Therapeutics | $23.71 | 2025 | Korlym |
| Eisai INC. | $23.03 | 2023 | |
| Hologic Sales and Service, LLC | $21.48 | 2025 | Aptima |
| Baxter Healthcare | $20.48 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Axsome Therapeutics, INC. | $18.87 | 2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $17.18 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.58 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $16.22 | 2024 | Opsumit, Uptravi |
| Novavax INC | $16.16 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Ani Pharmaceuticals, INC. | $14.99 | 2025 | Purified Cortrophin Gel |
| Astellas Pharma US INC | $13.91 | 2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $13.22 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.06 | 2023 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.